Raymond Debbane - Director at LEXICON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
LXRX on Nasdaq
All Insider Reports
All Insider Reports

Raymond Debbane - trading volume in the past year for LEXICON PHARMACEUTICALS, INC.

Holdings reported by Raymond Debbane for LEXICON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 35,402,689 $53,104,033 $1.50 25 Feb 2026 By Invus, L.P. and related parties
Common Stock 7,362,368 $11,043,552 $1.50 25 Feb 2026 By Invus Public Equities, L.P. and related parties
Common Stock 5,451,204 $8,176,806 $1.50 25 Feb 2026 By Invus US Partners, LLC and related parties
Common Stock 1,906,186 $2,840,217 $1.49 25 Feb 2026 Direct
Common Stock 1,538,462 $2,307,693 $1.50 25 Feb 2026 By Avicenna Life Sci Master Fund LP and related parties
Restricted Stock Units 89,312 $96,442 $2.62 03 Jun 2025 Direct Common Stock
Stock Option (Right to Buy) 103,806 03 Jun 2025 Direct Common Stock

Transactions reported by Raymond Debbane for LEXICON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.